Nancy E. Katz - 01 May 2025 Form 4 Insider Report for NeuroMetrix, Inc. (NURO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 May 2025, 17:52:59 UTC
Prior SEC filing
24 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas T. Higgins, Attorney-in-fact

Key filing fact

Nancy E. Katz filed Form 4 for NeuroMetrix, Inc. (NURO) on 05 May 2025.

Key facts

  • This page summarizes Nancy E. Katz's Form 4 filing for NeuroMetrix, Inc. (NURO).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 05 May 2025, 17:52.

Change

  • Previous filing in this sequence was filed on 24 May 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001189692 Primary reporting owner

KATZ NANCY E

Relationship
Director
Address
C/O NEUROMETRIX, INC., 4B GILL STREET, WOBURN
Signature
/s/ Thomas T. Higgins, Attorney-in-fact
Signature date
05 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NURO transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-7,602
Change %
-100%
Price
Shares after
0
Date
01 May 2025
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NURO transaction Derivative

Restricted Stock Unit

Disposed to Issuer

Transaction value
Shares
-13,730
Change %
-100%
Price
Shares after
0
Date
01 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
13,730
Exercise price
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated December 17, 2024 (the "Merger Agreement"), by and among the Issuer, electroCore, Inc., a Delaware corporation ("Parent"), and Nexus Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub").

Footnote F2

Pursuant to the Merger Agreement, as of the effective time of the Merger (the "Effective Time"), each share of common stock, par value $0.0001 per share, of the Issuer that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive (i) an amount in cash (the "Per Share Cash Consideration') equal to a pro rata share of the Company's balance of net cash at the Effective Time, after deduction of certain pro rata payments made accordance with the Issuer's Amended and Restated Management Retention and Incentive Plan, without interest and (ii) one contingent value right (a "CVR") representing the right to receive contingent payments subject to the terms and conditions set forth in a contingent value rights agreement entered into between Parent and Equiniti Trust Company, LLC.

Footnote F3

Pursuant to the terms of the Merger Agreement, at the Effective Time, each restricted stock unit (each, an "RSU") granted by the Issuer that was outstanding immediately prior to the Effective Time was converted into the right to receive (i) an amount of cash equal to the product of (A) the number of shares of common stock then underlying such RSU multiplied by (B) the Per Share Cash Consideration and (ii) CVRs in an amount equal to the total number of shares of common stock then underlying such RSUs.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .